BizCommunity - 22 Nov 2022
ADF invests over $6m to develop the pharmaceutical sector in Southern and Eastern Africa
The Board of Directors of the African Development Fund (ADF), the concessional lending arm of the African Development Bank Group on 2 November 2022 in Abidjan, approved a $6.63m grant to the Common Market for Eastern and Southern Africa (Comesa) to develop the pharmaceutical sector in the sub-region.
The project, which will be implemented over three years (2023-2025), is institutional support to develop the region’s pharmaceutical industry.
In particular, it will build the capacity of pharmaceutical regulatory bodies, product quality control and management systems, and research and development institutions.
The aim is to achieve the manufacture and marketing of safe, quality pharmaceutical products, for Covid-19 and other diseases.
The project will support the sub-regional body in implementing continental strategies on pharmaceutical manufacturing and assist it in streamlining and harmonising drug registration processes, as well as ensuring access to essential medical products and technologies.
An information platform for pharmaceutical manufacturers, importers and exporters will also be created.
Read more:
